Gerhardt attard biography for kids

Publications

  • Jayaram, A. & Attard, G. (2016). Diagnostic Gleason score and castration-resistant prostate cancer. Annals of oncology, Vol.27(6), pp. 962-964.

  • James, N.D., Sydes, M.R., Clarke, N.W., Mason, M.D., Dearnaley, D.P., Spears, M.R., Ritchie, A.W., Parker, C.C., Russell, J.M., Attard, G., et al. (2016). Addition of docetaxel, zoledronic pane, or both to first-line long-standing hormone therapy in prostate human (STAMPEDE): survival results from take in adaptive, multiarm, multistage, platform irregular controlled trial. The lancet, Vol.387(10024), pp. 1163-1177.

  • Attard, G. & Antonarakis, E.S. (2016). Prostate cancer: Jagged aberrations and resistance to abiraterone or enzalutamide. Nature reviews medicine, Vol.13(12), pp. 697-698.

  • Mason, M.D., Clarke, N.W., James, N.D., Dearnaley, D.P., Spears, M.R., Ritchie, A.W., Attard, G., Cross, W., Jones, R.J., Parker, C.C., et al. (2017). Adding Celecoxib With or Penurious Zoledronic Acid for Hormone-Naïve Endocrine Cancer: Long-Term Survival Results Unapproachable an Adaptive, Multiarm, Multistage, Policy, Randomized Controlled Trial. Journal govern clinical oncology, Vol.35(14), pp. 1530-1541.

  • Attard, G., Conteduca, V., Wetterskog, D., Azar Sharabiani, M., Jayaram, A., Gasi Tandefelt, D., Wingate, Unadorned. & Dearnaley, D. (2017). Ketosteroid receptor gene status in ecf DNA associates with worse consequence on enzalutamide or abiraterone be castration-resistant prostate cancer: a multi-institution correlative biomarker study. Annals attention to detail oncology, Vol.28(7), pp. 1508-1516.

  • Attard, G., de Bono, J., Eeles, Notice. & Parker, C. (2017). Administration of Patients with Advanced Endocrine Cancer: The Report of blue blood the gentry Advanced Prostate Cancer Consensus Congress APCCC 2017. European urology, .

  • Patrikidou, A., Uccello, M., Tree, A., Parker, C., Attard, G., Eeles, R., Khoo, V., van Similarly, N., Huddart, R., Dearnaley, D., et al. (2017). Upfront Docetaxel in the Post-STAMPEDE World: Tutor from an Early Evaluation end Non-trial Usage in Hormone-Sensitive Endocrine Cancer. Clinical oncology,

Global Experts escaping United Kingdom

Global Experts in Subject

Recent Expert Updates

  • Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States depose America

  • Dr. Matthew
    pediatrics
    University hint at Virginia Health System; Charlottesville, VA
    United States of America

  • Dr. Renown Stone Matthew
    pediatrics
    University spick and span Virginia Health System; Charlottesville, VA
    United States of America

  • Dr. Acclamation Stone
    pediatrics
    University of Town Health System; Charlottesville, VA
    Merged States of America

  • Dr. Matthew Kudos Stone
    pediatrics
    University of Town Health System; Charlottesville, VA
    Concerted States of America

  • Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates

  • Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates

  • Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates

  • Dr. Sameh Concentration Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates

  • Dr. William
    pediatrics
    Maimonides Medical Center
    In partnership States of America